Latest Insider Transactions at Rx Sight, Inc. (RXST)
This section provides a real-time view of insider transactions for Rx Sight, Inc. (RXST). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of RxSight, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of RxSight, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 02
2022
|
William J Phd Link |
BUY
Grant, award, or other acquisition
|
Direct |
10,349
+17.9%
|
-
|
|
Jun 02
2022
|
Shweta Maniar |
BUY
Grant, award, or other acquisition
|
Direct |
4,312
+15.5%
|
-
|
|
Jun 02
2022
|
Robert J Palmisano |
BUY
Grant, award, or other acquisition
|
Direct |
8,624
+28.16%
|
-
|
|
Jun 02
2022
|
Bakker Juliet Tammenoms |
BUY
Grant, award, or other acquisition
|
Direct |
10,349
+26.5%
|
-
|
|
Jun 02
2022
|
Robert Keith Warner |
BUY
Grant, award, or other acquisition
|
Direct |
8,624
+28.16%
|
-
|
|
May 17
2022
|
William J Phd Link |
SELL
Other acquisition or disposition
|
Indirect |
375,000
-22.84%
|
-
|
|
Mar 15
2022
|
William J Phd Link |
SELL
Other acquisition or disposition
|
Indirect |
375,000
-18.59%
|
-
|
|
Jan 03
2022
|
Shweta Maniar |
BUY
Grant, award, or other acquisition
|
Direct |
19,196
+50.0%
|
-
|
|
Nov 17
2021
|
Jesse Anderson Corley |
BUY
Open market or private purchase
|
Direct |
8,150
+36.78%
|
$97,800
$12.48 P/Share
|
|
Aug 05
2021
|
Ilya Goldshleger |
BUY
Open market or private purchase
|
Indirect |
1,372
+50.0%
|
$17,836
$13.69 P/Share
|
|
Aug 05
2021
|
Ilya Goldshleger |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$14,000
$14.49 P/Share
|
|
Aug 05
2021
|
Eric Weinberg |
BUY
Open market or private purchase
|
Indirect |
9
+0.96%
|
$126
$14.9 P/Share
|
|
Aug 05
2021
|
Ronald M Md Kurtz President & CEO |
BUY
Open market or private purchase
|
Indirect |
3,638
+0.45%
|
$47,294
$13.85 P/Share
|
|
Aug 04
2021
|
Eric Weinberg |
BUY
Open market or private purchase
|
Indirect |
615
+40.17%
|
$9,840
$16.25 P/Share
|
|
Aug 03
2021
|
Eric Weinberg |
BUY
Open market or private purchase
|
Indirect |
1
+0.33%
|
$17
$17.03 P/Share
|
|
Aug 03
2021
|
Robert Keith Warner |
BUY
Open market or private purchase
|
Indirect |
43,750
+43.37%
|
$700,000
$16.0 P/Share
|
|
Aug 03
2021
|
Robert Keith Warner |
BUY
Grant, award, or other acquisition
|
Direct |
13,378
+43.18%
|
-
|
|
Aug 03
2021
|
Robert J Palmisano |
BUY
Grant, award, or other acquisition
|
Direct |
13,378
+43.18%
|
-
|
|
Aug 03
2021
|
Julie Andrews |
BUY
Open market or private purchase
|
Direct |
15,625
+35.01%
|
$250,000
$16.0 P/Share
|
|
Aug 03
2021
|
Julie Andrews |
BUY
Grant, award, or other acquisition
|
Direct |
13,378
+43.18%
|
-
|
|
Aug 03
2021
|
Ronald M Md Kurtz President & CEO |
BUY
Open market or private purchase
|
Direct |
125,000
+50.0%
|
$2,000,000
$16.0 P/Share
|
|
Aug 03
2021
|
Eric Weinberg |
BUY
Open market or private purchase
|
Direct |
31,250
+50.0%
|
$500,000
$16.0 P/Share
|
|
Aug 03
2021
|
William J Phd Link |
BUY
Open market or private purchase
|
Direct |
31,250
+45.71%
|
$500,000
$16.0 P/Share
|
|
Aug 03
2021
|
William J Phd Link |
BUY
Conversion of derivative security
|
Indirect |
2,016,778
+50.0%
|
-
|
|
Aug 03
2021
|
Jesse Anderson Corley |
BUY
Open market or private purchase
|
Indirect |
78,125
+15.19%
|
$1,250,000
$16.0 P/Share
|
|
Aug 03
2021
|
Bakker Juliet Tammenoms |
BUY
Open market or private purchase
|
Indirect |
625,000
+27.96%
|
$10,000,000
$16.0 P/Share
|
|
Aug 03
2021
|
Bakker Juliet Tammenoms |
BUY
Conversion of derivative security
|
Indirect |
1,863,613
+50.0%
|
-
|
|
Aug 03
2021
|
Bakker Juliet Tammenoms |
BUY
Open market or private purchase
|
Direct |
12,500
+40.51%
|
$200,000
$16.0 P/Share
|
|
Aug 03
2021
|
Bruce C Robertson Director |
BUY
Conversion of derivative security
|
Indirect |
1,385,037
+50.0%
|
-
|
|
Aug 03
2021
|
Daniel Mark Schwartz Director |
BUY
Conversion of derivative security
|
Direct |
3,969
+0.96%
|
-
|
|
Aug 03
2021
|
Richard M. Wolfen Director |
BUY
Conversion of derivative security
|
Indirect |
1,489,805
+45.81%
|
-
|
|
Aug 03
2021
|
Richard M. Wolfen Director |
BUY
Conversion of derivative security
|
Direct |
76,974
+49.61%
|
-
|
|
Aug 03
2021
|
Rx Sight I, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,016,778
+50.0%
|
-
|
|
Aug 02
2021
|
Eric Weinberg |
BUY
Open market or private purchase
|
Indirect |
90
+23.08%
|
$1,530
$17.04 P/Share
|
|
Jul 30
2021
|
Eric Weinberg |
BUY
Open market or private purchase
|
Indirect |
210
+50.0%
|
$3,360
$16.94 P/Share
|
|
Jul 30
2021
|
Jesse Anderson Corley |
BUY
Grant, award, or other acquisition
|
Direct |
5,859
+50.0%
|
-
|
|
Jul 30
2021
|
William J Phd Link |
BUY
Grant, award, or other acquisition
|
Direct |
5,859
+50.0%
|
-
|
|
Jul 30
2021
|
Bakker Juliet Tammenoms |
BUY
Grant, award, or other acquisition
|
Direct |
5,859
+50.0%
|
-
|